Highly Efficient Domino Reaction for the Synthesis of the Erythrina and B-Homoerythrina Alkaloid Skeleton

Lutz F. Tietze; Nina Tölle; Claudia Noll

doi:10.1055/s-2008-1032091

Subscribe to RSS

Please copy the URL and add it into your RSS Feed Reader.

https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000083.xml

Share / Bookmark

Facebook X Linkedin Weibo

Download PDF

Synlett 2008(4): 525-528
DOI: 10.1055/s-2008-1032091

LETTER

Highly Efficient Domino Reaction for the Synthesis of the Erythrina and B-Homoerythrina Alkaloid Skeleton

Lutz F. Tietze*, Nina Tölle, Claudia Noll
Institut für Organische und Biomolekulare Chemie, Georg-August-Universität, Tammannstr. 2, 37077 Göttingen, Germany
Fax: +49(551)399476; e-Mail: ltietze@gwdg.de;

Further Information

Publication History

Received 28 October 2007
Publication Date:
12 February 2008 (online)

Abstract
Full Text
References

Permissions and Reprints All articles of this category

Abstract

A Lewis acid catalyzed domino-amidation-spirocyclization reaction is described which provides the spirocyclic core of the erythrina and B-homoerythrina alkaloids, forming three bonds in one process.

Key words

domino reactions - erythrina alkaloids - spiro compounds - Lewis acids - indolizidine - lactams

References and Notes

1a Tietze LF. Brasche G. Gericke KM. Domino Reactions in Organic Synthesis Wiley-VCH; Weinheim: 2006.

Crossref Google Scholar
1b Tietze LF. Haunert F. In Stimulating Concepts in Chemistry Shibasaki M. Stoddart JF. Vögtle F. Wiley-VCH; Weinheim: 2000. p.39

Crossref Google Scholar
1c Tietze LF. Modi A. Med. Res. Rev. 2000, 20: 304

Crossref Google Scholar
1d Tietze LF. Chem. Rev. 1996, 115

Crossref Google Scholar
1e Tietze LF. Beifuss U. Angew. Chem., Int Ed. Engl. 1993, 32: 131

Crossref Google Scholar
2 Krukoff BA. Barneby RC. Mem. New York Bot. Gard. 1970, 20: 1

Google Scholar
3a Chawla AS. Kapor VK. In Handbook of Plant and Fungal Toxicants D’Mello JF. CRC Press; New York: 1997. p.37

Google Scholar
3b Bhakuni DS. J. Indian Chem. Soc. 2002, 203

Google Scholar
3c Lehman AJ. J. Pharmacol. 1937, 69

Google Scholar
3d Williams M. Robinson JL. J. Neurosci. 1984, 2906

Google Scholar
3e Decker MW. Anderson DJ. Brioni JD. Donnelly-Roberts DL. Kang CH. O’Neil AB. Piattoni-Kaplan M. Swanson S. Sullivan JP. Eur. J. Pharmacol. 1995, 79

Google Scholar
4a Boekelheide V. In The Alkaloids Vol. 7: Manske RHF. Academic Press; New York: 1960. p.201

Crossref Google Scholar
4b Hill RK. In The Alkaloids Vol. 9: Manske RHF. Academic Press; New York: 1967. p.483

Crossref Google Scholar
4c Dyke SF. Quessy SN. In The Alkaloids Vol. 18: Rodrigo RGA. Academic Press; New York: 1981. p.1

Crossref Google Scholar
4d Jackson AH. In Chemistry and Biology of Isoquinoline Alkaloids Phillipson JD. Margaret MF. Zenk MH. Springer; Berlin: 1985. p.62

Crossref Google Scholar
4e Chawla AS. Jackson AH. Nat. Prod. Rep. 1984, 1: 371

Crossref Google Scholar
5a Stanislawski PC. Willis AC. Banwell MG. Org. Lett. 2006, 8: 2143

Crossref Google Scholar
5b Padwa A. Wang Q. J. Org. Chem. 2006, 71: 7391

Crossref Google Scholar
5c Ganguly AK. Wang CH. Biswas D. Misiaszek J. Micula A. Tetrahedron Lett. 2006, 47: 5539

Crossref Google Scholar
5d Gao S. Tu YQ. Hu X. Wang S. Hua R. Jiang Y. Zhao Y. Fan X. Zhang S. Org. Lett. 2006, 8: 2373

Crossref Google Scholar
5e Fukumoto H. Takahashi K. Ishihara J. Hatakeyama S. Angew. Chem. Int. Ed. 2006, 45: 2731

Crossref Google Scholar
7 El Bialy SAA. Braun H. Tietze LF. Angew. Chem. Int. Ed. 2004, 43: 5391

Crossref Google Scholar

6

General Procedure
To a stirred solution of amine 2 (1.00 equiv) in MeCN (0.5 mL/mmol) was added dropwise at 0 °C AlMe₃ (2.00 M in toluene, 2.00 equiv), then In(OTf)₃ (4-25 mol%) and the ester 3 (1.00 equiv), and stirring was continued for 3-17 h at r.t. or the mixture was heated to 100-180 °C under microwave irradiation. The reaction mixture was cooled to 0 °C, TfOH (3.5 equiv) was added dropwise and stirring was continued for 5 h at r.t. Subsequently, the mixture was quenched by addition of sat. aq NaHCO₃ at 0 °C with stirring for 20 min. The mixture was extracted with EtOAc, the combined organic layers were washed with brine, dried over Na₂SO₄, and the solvent was removed under reduced pressure. The crude product was subjected to column chromatography to yield 38-99% of the spirocycle 4.
Compound 4a: ¹H NMR (300 MHz, DMSO): d = 1.35-1.60 (m, 5 H, 3-H₂, 2-H₂, 1-H_a), 1.75-1.82 (m, 2 H, 4-H₂), 1.95-1.99 (m, 1 H, 1-H_b), 2.12 (m_c, 2 H, 7-H₂), 2.54-2.60 (m, 1 H, 6-H), 2.63 (ddd, J = 3.0, 6.0, 16.5 Hz, 1 H, 11-H_a), 2.80 (ddd, J = 7.4, 10.0, 16.5 Hz, 1 H, 11-H_b), 3.15 (ddd, J = 6.0, 10.0, 13.2 Hz, 1 H, 10-H_a), 3.71 (s, 3 H, OCH₃), 3.76 (s, 3 H, OCH₃), 3.86 (ddd, J = 3.0, 7.4, 13.2 Hz, 1 H, 10-H_b), 6.67 (s, 1 H, 17-H), 6.91 (s, 1 H, 14-H). ¹³C NMR (300 MHz, DMSO): d = 20.06 (C-2), 20.57 (C-3), 26.14 (C-11), 27.17 (C-1), 34.26 (C-10), 35.01 (C-4), 36.29 (C-7), 36.67 (C-6), 55.42 (OCH₃), 55.74 (OCH₃), 61.75 (C-5), 108.7 (C-14), 112.5 (C-17), 125.5 (C-12), 134.7 (C-13), 147.0 (C-16), 147.5 (C-15), 173.6 (C-8).
Compound 4b: ¹H NMR (300 MHz, DMSO): d = 1.18-1.42 (m, 2 H, 11-H_a, 13*-H_a), 1.42-1.69 (m, 5 H, 2-H₂, 12*-H₂, 13*-H_b), 1.69-1.82 (m, 2 H, 1-H₂), 2.05 (dd, J = 18.5, 6.2 Hz, 1 H, 14-H_a), 2.18-2.26 (m, 1 H, 11-H_b), 2.33-2.47 (m, 1 H, 14-H_b), 2.52 (d, J = 5.9 Hz, 1 H, 6-H_a), 2.63 (m_c, 1 H, 14a-H), 2.84-2.99 (m, 1 H, 6-H_b), 3.19 (td, J = 12.3, 5.9 Hz, 1 H, 5-H_a), 3.70 (s, 3 H, OCH₃), 3.73 (s, 3 H, OCH₃), 4.53 (dd, J = 13.2, 7.5 Hz, 1 H, 5-H_b), 6.62 (s, 1 H, 7-H), 6.82 (s, 1 H, 10-H). ¹³C NMR (300 MHz, DMSO): d = 21.42 (C-13*), 22.15 (C-12*), 25.07 (C-1), 25.60 (C-2), 26.06 (C-6), 28.14 (C-14), 34.48 (C-5), 34.77 (C-14a), 39.58 (C-11), 55.32 (OCH₃), 55.89 (OCH₃), 60.99 (C-10b), 107.2 (C-10), 112.9 (C-7), 126.5 (C-6a), 135.8 (C-10a), 146.9 (C-9), 147.4 (C-8), 171.0 (C-3).
Compound 4c: ¹H NMR (300 MHz, DMSO): d = 1.28-1.48 (m, 3 H, 3-H₂, 1-H_a), 1.49-1.58 (m, 2 H, 2-H₂), 1.71-1.75 (m, 1 H, 4-H_a), 1.78-1.83 (m, 1 H, 4-H_b), 1.91-1.99, (m, 1 H, 1-H_b), 2.09-2.14 (m, 2 H, 7-H₂), 2.49-2.54 (m, 1 H, 6-H), 2.59-2.67 (m, 1 H, 11-H_a), 2.73-2.87 (m, 1 H, 11-H_b), 3.11-3.21 (m, 1 H, 10-H_a), 3.78-3.85 (m, 1 H, 10-H_b), 5.94 (s, 2 H, 18-H₂), 6.65 (s, 1 H, 17-H), 6.97 (s, 1 H, 14-H). ¹³C NMR (300 MHz, DMSO): d = 19.90 (C-2), 20.49 (C-3), 26.58 (C-11), 27.02 (C-1), 34.25 (C-10), 35.01 (C-4), 36.22 (C-7), 36.71 (C-6), 62.13 (C-5), 100.7 (C-18), 104.9 (C-14), 108.7 (C-17), 126.8 (C-12), 135.9 (C-13), 145.6 (C-16), 145.7 (C-15), 173.6 (C-8).
Compound 4d: ¹H NMR (300 MHz, DMSO): d = 1.20-1.35 (m, 2 H, 11-H_a, 13*-H_a), 1.35-1.52 (m, 2 H, 1-H₂), 1.50-1.80 (m, 5 H, 2-H₂, 12*-H₂, 13*-H_b), 2.04 (dd, J = 18.6, 6.6 Hz, 1 H, 14-H_a), 2.18-2.25 (m, 1 H, 11-H_b), 2.32-2.44 (m, 1 H, 14-H_b), 2.55-2.70 (m, 2 H, 6-H_a, 14a-H), 2.80-2.92 (m, 1 H, 6-H_b), 3.14 (td, J = 11.9, 5.8 Hz, 1 H, 5-H_a), 4.52 (dd, J = 13.7, 7.4 Hz, 1 H, 5-H_b), 5.96 (s, 2 H, OCH₂O), 6.61 (s, 1 H, 7-H), 6.92 (s, 1-H, 10-H).¹³C NMR (300 MHz, DMSO): d = 21.36 (C-13*), 22.07 (C-12*), 25.05 (C-1), 25.56 (C-2), 26.53 (C-6), 28.10 (C-14), 34.22 (C-5), 34.83 (C-14a), 39.62 (C-11), 61.12 (C-10b), 100.5 (OCH₂O), 103.3 (C-10), 109.1 (C-7), 127.6 (C-6a), 137.0 (C-10a), 145.4 (C-9), 145.5 (C-8), 170.8 (C-3).
Compound 4e: ¹H NMR (300 MHz, DMSO): d = 1.48-1.64 (m, 6 H, 11-H_a, 10-H₂, 9-H₂, 8-H_a), 1.82-1.87 (m, 1 H, 11-H_b), 1.94-1.99 (m, 1 H, 8-H_b), 2.10-2.19 (m, 2 H, 4-H_a, 8a-H), 2.39-2.48 (m, 1 H, 4-H_b), 2.48-2.74 (m, 2 H, 12-H₂), 2.96 (td, J = 12.3, 6.7 Hz, 1 H, 5-H_a), 4.00-4.11 (qd, 1 H, J = 6.5, 1.3 Hz, 5-H_b), 6.85 (d, J = 5.4 Hz, 1 H, 3-H), 7.35 (d, J = 5.4 Hz, 1 H, 2-H). ¹³C NMR (300 MHz, DMSO): d = 19.57 (C-10), 21.00 (C-9), 24.46 (C-11), 25.10 (C-12), 33.16 (C-5), 34.43 (C-8), 34.54 (C-4), 40.33 (C-8a), 61.03 (C-12a), 122.9 (C-2), 126.9 (C-3), 132.4 (C-12b), 139.2 (C-3a), 171.0 (C-7).
Compound 4f: ¹H NMR (300 MHz, DMSO-d ₆): d = 1.35-1.61 (m, 4 H, 12-H_a, 13-H₂, 12-H_b), 1.61-1.80 (m, 4 H, 10-H₂, 9-H_a, 11-H_a), 1.84-1.94 (m, 2 H, 11-H_b), 2.03-2.09 (m, 1 H, 9a-H), 2.11-2.25 (m, 2 H, 8-H_a, 9-H_b), 2.37-2.49 (m, 1 H, 8-H_b), 2.53 (ddd, J = 1.0, 5.3, 16.5 Hz, 1 H, 4-H_a), 2.70 (ddd, J = 6.8, 11.7, 16.5 Hz, 1 H, 4-H_b), 3.16 (ddd, J = 5.3, 11.7, 13.3 Hz, 1 H, 5-H_a), 4.58 (ddd, J = 1.0, 6.8, 13.3 Hz, 1 H, 5-H_b), 6.80 (d, J = 5.0 Hz, 1 H, 3-H), 7.34 (d, J = 5.0 Hz, 1 H, 2-H). ¹³C NMR (75 MHz, DMSO-d ₆): d = 21.69 (C-12), 22.77 (C-10), 23.10 (C-13), 24.30 (C-4), 26.82 (C-11), 29.68 (C-8), 34.88 (C-5), 38.20 (C-9), 39.34 (C-9a), 61.27 (C-13a), 122.8 (C-2), 127.3 (C-3), 134.3 (C-3a), 142.1 (C-13b), 170.2 (C-7).
Compound 4g: ¹H NMR (300 MHz, DMSO-d ₆): d = 1.46-1.68 (m, 6 H, 5-H₂, 6-H₂, 7-H_a, 4-H_a), 1.85-2.99 (m, 2 H, 7-H_b, 4-H_b), 2.14 (dd, J = 6.9, 14.0 Hz, 8-H_a), 2.21-2.29 (m, 1 H, 7a-H), 2.35 (ddd, J = 0.8, 8.9, 14.0 Hz, 1 H, 8-H_b), 2.70-2.86 (m, 2 H, 12-H₂), 3.01-3.11 (m, 1 H, 11-H_a), 4.09-4.16 (m, 1 H, 11-H_b), 7.18 (d, J = 5.3 Hz, 1 H, 3-H), 7.35 (d, J = 5.3 Hz, 1 H, 2-H). ¹³C NMR (75 MHz, DMSO-d ₆): d = 19.95 (C-5), 20.23 (C-6), 23.88 (C-12), 24.97 (C-7), 33.45 (C-11), 34.12 (C-4), 35.08 (C-8), 37.68 (C-7a), 61.10 (C-3b), 123.4 (C-2), 124.3 (C-3), 132.3 (C-12a), 140.8 (C-3a), 171.9 (C-9).
Compound 4h: ¹H NMR (300 MHz, DMSO-d ₆): d = 1.21-1.38 (m, 1 H, 4-H_a), 1.38-1.55 (m, 4 H, 4-H_b, 8-H₂, 6-H_a), 1.55-1.68 (m, 2 H, 5-H₂), 1.68-1.78 (m, 2 H, 7-H₂), 2.09 (m_c, 1 H, 9-H_a), 2.17-2.24 (m, 1 H, 6-H_b), 2.37-2.47 (m, 2 H, 7a-H, 9-H_b), 2.63 (dd, J = 5.3, 16.2 Hz, 1 H, 13-H_a), 2.90 (ddd, J = 6.9, 11.7, 16.2 Hz, 1 H, 13-H_b), 3.23 (ddd, J = 5.3, 11.7, 13.2 Hz, 1 H, 12-H_a), 4.58 (dd, J = 6.9, 13.2 Hz, 1 H, 12-H_b), 7.00 (d, J = 5.4 Hz, 1 H, 3-H), 7.27 (d, J = 5.4 Hz, 1 H, 2-H). ¹³C NMR (75 MHz, DMSO-d ₆): d = 21.35 (C-4), 22.78 (C-8), 23.06 (C-13), 24.69 (C-7), 25.76 (C-5), 28.67 (C-9), 35.06 (C-12), 36.46 (C-7a), 38.31 (C-6), 61.42 (C-3b), 122.7 (C-3), 123.2 (C-2), 134.1 (C-13a), 143.21 (C-3a), 171.3 (C-10).